Testing effectiveness (Phase 2)Study completedNCT01649297
What this trial is testing
A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy
Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 983